Notably, although clinical studies have not consistently found a correlation between anti‐ganglioside antibodies and peripheral nervous system manifestations in SLE, emerging data suggest a potential role for anti‐Ro antibodies in peripheral neuropathy among patients with SLE and lupus nephritis [1]. The gene discussed is CALR; the disease is systemic lupus erythematosus.